Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Won Bae Kim

Showing results (261-270 of 323) with videos related to

Pageof 33
Sort By:
Taehan Kan Hakhoe Chi = the Korean Journal of Hepatology|December 31, 2002
[Suppressive effects of antioxidant DA-9601 on hepatic fibrosis in rats]Jae Youn Cheong, Tae Young Oh, Ki Myung Lee, et al.
Endocrine Journal|March 24, 2007
Clinical features and prognostic factors for survival in patients with poorly differentiated thyroid carcinoma and comparison to the patients with the aggressive variants of papillary thyroid carcinomaTae Sik Jung, Tae Yong Kim, Kyung Won Kim, et al.
The Journal of Clinical Endocrinology and Metabolism|January 19, 2010
Empiric high-dose 131-iodine therapy lacks efficacy for treated papillary thyroid cancer patients with detectable serum thyroglobulin, but negative cervical sonography and 18F-fluorodeoxyglucose positron emission tomography scanWon Gu Kim, Jin-Sook Ryu, Eui Young Kim, et al.
Thyroid : Official Journal of the American Thyroid Association|April 21, 2022
Lenvatinib Compared with Sorafenib as a First-Line Treatment for Radioactive Iodine-Refractory, Progressive, Differentiated Thyroid Carcinoma: Real-World Outcomes in a Multicenter Retrospective Cohort StudyMijin Kim, Meihua Jin, Min Ji Jeon, et al.
Endocrinology and Metabolism (Seoul, Korea)|December 1, 2014
Lack of Associations between Body Mass Index and Clinical Outcomes in Patients with Papillary Thyroid CarcinomaHyemi Kwon, Mijin Kim, Yun Mi Choi, et al.
The Korean Journal of Internal Medicine|May 18, 2018
Association between urinary sodium levels and iodine status in KoreaJonghwa Ahn, Jang Ho Lee, Jiwoo Lee, et al.
Endocrinology and Metabolism (Seoul, Korea)|November 3, 2021
Clinicopathological Characteristics and Disease-Free Survival in Patients with Hürthle Cell Carcinoma: A Multicenter Cohort Study in South KoreaMeihua Jin, Eun Sook Kim, Bo Hyun Kim, et al.
Clinical Endocrinology|June 23, 2021
Clinical implications of age and excellent response to therapy in patients with high-risk differentiated thyroid carcinomaMeihua Jin, Jonghwa Ahn, Yu-Mi Lee, et al.
Endocrine|July 31, 2020
Real-world experience of lenvatinib in patients with advanced anaplastic thyroid cancerMijin Kim, Jonghwa Ahn, Dong Eun Song, et al.
Thyroid : Official Journal of the American Thyroid Association|May 31, 2018
Changes in Serum Thyroglobulin Levels After Lobectomy in Patients with Low-Risk Papillary Thyroid CancerSuyeon Park, Min Ji Jeon, Hye-Seon Oh, et al.
Pageof 33

Showing results (261-270 of 323) with videos related to

Sort By:
Pageof 33
Taehan Kan Hakhoe Chi = the Korean Journal of Hepatology|December 31, 2002
[Suppressive effects of antioxidant DA-9601 on hepatic fibrosis in rats]Jae Youn Cheong, Tae Young Oh, Ki Myung Lee, et al.
Endocrine Journal|March 24, 2007
Clinical features and prognostic factors for survival in patients with poorly differentiated thyroid carcinoma and comparison to the patients with the aggressive variants of papillary thyroid carcinomaTae Sik Jung, Tae Yong Kim, Kyung Won Kim, et al.
The Journal of Clinical Endocrinology and Metabolism|January 19, 2010
Empiric high-dose 131-iodine therapy lacks efficacy for treated papillary thyroid cancer patients with detectable serum thyroglobulin, but negative cervical sonography and 18F-fluorodeoxyglucose positron emission tomography scanWon Gu Kim, Jin-Sook Ryu, Eui Young Kim, et al.
Thyroid : Official Journal of the American Thyroid Association|April 21, 2022
Lenvatinib Compared with Sorafenib as a First-Line Treatment for Radioactive Iodine-Refractory, Progressive, Differentiated Thyroid Carcinoma: Real-World Outcomes in a Multicenter Retrospective Cohort StudyMijin Kim, Meihua Jin, Min Ji Jeon, et al.
Endocrinology and Metabolism (Seoul, Korea)|December 1, 2014
Lack of Associations between Body Mass Index and Clinical Outcomes in Patients with Papillary Thyroid CarcinomaHyemi Kwon, Mijin Kim, Yun Mi Choi, et al.
The Korean Journal of Internal Medicine|May 18, 2018
Association between urinary sodium levels and iodine status in KoreaJonghwa Ahn, Jang Ho Lee, Jiwoo Lee, et al.
Endocrinology and Metabolism (Seoul, Korea)|November 3, 2021
Clinicopathological Characteristics and Disease-Free Survival in Patients with Hürthle Cell Carcinoma: A Multicenter Cohort Study in South KoreaMeihua Jin, Eun Sook Kim, Bo Hyun Kim, et al.
Clinical Endocrinology|June 23, 2021
Clinical implications of age and excellent response to therapy in patients with high-risk differentiated thyroid carcinomaMeihua Jin, Jonghwa Ahn, Yu-Mi Lee, et al.
Endocrine|July 31, 2020
Real-world experience of lenvatinib in patients with advanced anaplastic thyroid cancerMijin Kim, Jonghwa Ahn, Dong Eun Song, et al.
Thyroid : Official Journal of the American Thyroid Association|May 31, 2018
Changes in Serum Thyroglobulin Levels After Lobectomy in Patients with Low-Risk Papillary Thyroid CancerSuyeon Park, Min Ji Jeon, Hye-Seon Oh, et al.
Pageof 33